News

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

February 23, 2021

BALTIMORE–(BUSINESS WIRE)–Akers Biosciences, Inc. (Nasdaq: AKER), with its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today announced new data from a study conducted by Eurofins Discovery Phenotypic Center of Excellence. MYMD-1 is being developed to treat autoimmune and…

Details

POSaBIT Announces Strategic Investment to Accelerate Next Phase of Growth

February 23, 2021

TORONTO & SEATTLE–(BUSINESS WIRE)–POSaBIT Systems Corporation (CSE: PBIT) (“POSaBIT” or the “Company”), a leading financial technology company delivering unique payment processing and point-of-sale (POS) systems for cash-only businesses with a focus on the cannabis industry, announces that it has closed a non-brokered private placement (the “Offering”) for gross proceeds of $2 million USD. The Offering…

Details

Global Pharmaceutical Cannabis Market Report 2020: Epidiolex Remains the Leading Pharmaceutical Cannabis Product – ResearchAndMarkets.com

February 23, 2021

DUBLIN–(BUSINESS WIRE)–The “The Impact Series: The Pharmaceutical Cannabis Report” report has been added to ResearchAndMarkets.com’s offering. This reports provides market research, competitor analysis and consumer data that will ensure you future-proof your business and maximise growth in this rapidly changing The report estimates that worldwide sales for pharmaceutical cannabinoid therapeutics will total almost US$800 million…

Details

Newly Listed on LSE, Kanabo Group Announces Partnership With the UK’s Biggest Cannabis Clinic Provider, LYPHE Group

February 23, 2021

LONDON–(BUSINESS WIRE)–Kanabo Group Plc, a medical cannabis company that recently debuted on London Stock Exchange, is delighted to announce it has signed its first UK medicinal cannabis distribution framework agreement with Astral Health Limited (“Astral Health”). Astral Health is fully owned by LYPHE Group, which is part of Drug Science’s Project Twenty21. According to the…

Details

Flower One Announces Vendor Conversions To Equity

February 22, 2021

LAS VEGAS & TORONTO–(BUSINESS WIRE)–Flower One Holdings Inc. (“Flower One” or the “Company”) (CSE: FONE) (OTCQX: FLOOF) (FSE: F11), a leading cannabis cultivator and producer in Nevada, is pleased to announce today that several vendors have agreed to convert their debt into equity shares of Flower One. These transactions are part of the Company’s restructuring…

Details

Germany Cannabis and CBD Consumer Report 2020: Usage, Purchase and Attitudes in the Cannabis, CBD and Infused Consumer Goods Markets – ResearchAndMarkets.com

February 22, 2021

DUBLIN–(BUSINESS WIRE)–The “Germany: Cannabis and CBD Consumer Report” has been added to ResearchAndMarkets.com’s offering. Germany is set to become one of the largest single markets for cannabis and CBD anywhere in the world. Despite the fact that millions of Germans are using CBD and cannabis, relatively little is currently known about these consumers. This report…

Details

Principal Financial Group Announces Shareholder Value Initiatives

February 22, 2021

DES MOINES, Iowa–(BUSINESS WIRE)–Principal Financial Group® (Nasdaq: PFG) today announced steps to enhance shareholder value by initiating a strategic review of its business mix, capital management, and capital deployment options. Principal® will be adding two new independent directors to its Board of Directors, Maliz Beams and a second director to be named at a later…

Details

An Exclusive Agreement for Commercialization of the Autoflower Trait of Cannabis

February 22, 2021

NESS ZIONA, Israel & HOLLISTER, Calif.–(BUSINESS WIRE)–NRGene (TASE: NRGN), a leading genomics AI company, and Kayagene, an innovator in Cannabis breeding, signed an agreement that grants NRGene a world-wide, exclusive license to commercialize the Cannabis autoflower trait and DNA markers linked to it. Utilizing NRGene’s proprietary genomic tools and Kayagene’s proprietary germplasm and breeding knowledge…

Details

Update On IGC’s Phase 1 Clinical Trial on Alzheimer’s Patients

February 22, 2021

POTOMAC, Md.–(BUSINESS WIRE)–India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) is pleased to announce the progress of its tetrahydrocannabinol (THC)-based phase 1 clinical trial, which was approved to proceed by the U.S. Food and Drug Administration (“FDA”) on July 30, 2020, as previously disclosed. On February 11, 2021, the Company completed administering…

Details

BevCanna Closes Transformative Acquisition of Naturo Group

February 22, 2021

VANCOUVER, British Columbia–(BUSINESS WIRE)–Diversified health and wellness; beverage and natural products company, BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) announces today that it has closed its previously announced acquisition of Naturo Group Investments Inc. (“Naturo”). The combination of these two emerging industry leaders creates a diversified health and wellness; beverage and natural…

Details

Bluma Wellness Inc. Announces Refiling of Interim Financial Statements

February 19, 2021

TORONTO–(BUSINESS WIRE)–Bluma Wellness Inc. (CSE: BWEL.U) announces that it has refiled its interim financial statements for the three and nine months ended September 30, 2020 (the “Interim Financial Statements”). The refiled Interim Financial Statements now include a notice, as required by Section 4.3(3)(a) of National Instrument 51-102 – Continuous Disclosure Obligations, indicating that the Interim…

Details

Leading CBD Health and Wellness Company cbdMD and Its Pet Product Line Paw CBD Both Win 2021 Product of the Year Awards

February 19, 2021

CHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, is proud to announce that both its cbdMD product line and its CBD pet product line, Paw CBD, have been named 2021 Product of the Year winners – with cbdMD serving as…

Details